As genetic evidence supporting this toxicological mechanism, a recent whole-exome sequencing study reported that severe thrombocytopenia in NSCLC patients treated with gemcitabine/carboplatin are associated with variant of DDX53 gene, a modulator of p53 mediated apoptosis [29]. This evidence concerns the gene DDX53 and non-small cell lung carcinoma.